130 related articles for article (PubMed ID: 26940164)
1. Second Primary Neoplasms in Patients With Uveal Melanoma: A SEER Database Analysis.
Laíns I; Bartosch C; Mondim V; Healy B; Kim IK; Husain D; Miller JW
Am J Ophthalmol; 2016 May; 165():54-64. PubMed ID: 26940164
[TBL] [Abstract][Full Text] [Related]
2. Cancer predisposition syndromes as a risk factor for early second primary neoplasms after childhood cancer - A national cohort study.
Waespe N; Belle FN; Redmond S; Schindera C; Spycher BD; Rössler J; Ansari M; Kuehni CE;
Eur J Cancer; 2021 Mar; 145():71-80. PubMed ID: 33423008
[TBL] [Abstract][Full Text] [Related]
3. Surgery vs. radiotherapy in patients with uveal melanoma : Analysis of the SEER database using propensity score matching and weighting.
Jang BS; Chang JH; Oh S; Lim YJ; Kim IH
Strahlenther Onkol; 2017 Nov; 193(11):931-942. PubMed ID: 28879443
[TBL] [Abstract][Full Text] [Related]
4. Risk of developing second malignant neoplasms in patients with neuroblastoma: a population study of the US SEER database.
Zhen H; Guan H; Ma J; Wang W; Jing S; Miao Z; Zhang F; Liu Z
Radiat Oncol; 2021 Nov; 16(1):228. PubMed ID: 34838090
[TBL] [Abstract][Full Text] [Related]
5. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
[TBL] [Abstract][Full Text] [Related]
6. Outcomes after diagnosis of mycosis fungoides and Sézary syndrome before 30 years of age: a population-based study.
Ai WZ; Keegan TH; Press DJ; Yang J; Pincus LB; Kim YH; Chang ET
JAMA Dermatol; 2014 Jul; 150(7):709-15. PubMed ID: 24718769
[TBL] [Abstract][Full Text] [Related]
7. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
8. Risk of Second Primary Malignancies in Patients With Follicular Lymphoma: A United States Population-based Study.
Giri S; Bhatt VR; Verma V; Pathak R; Bociek RG; Vose JM; Armitage JO
Clin Lymphoma Myeloma Leuk; 2017 Sep; 17(9):569-574. PubMed ID: 28709798
[TBL] [Abstract][Full Text] [Related]
9. Second Primary Malignancies in Patients With Melanoma Subtypes: Analysis of 120,299 Patients From the SEER Database (2000-2016).
Loya A; Gombos DS; Patel SP
Front Oncol; 2022; 12():853076. PubMed ID: 35372013
[TBL] [Abstract][Full Text] [Related]
10. Uveal melanoma: Long-term survival.
Radivoyevitch T; Zabor EC; Singh AD
PLoS One; 2021; 16(5):e0250939. PubMed ID: 34003826
[TBL] [Abstract][Full Text] [Related]
11. Non-ocular primary malignancies in patients with uveal melanoma: the Liverpool experience.
Heussen FM; Coupland SE; Kalirai H; Damato BE; Heimann H
Br J Ophthalmol; 2016 Mar; 100(3):356-9. PubMed ID: 26178903
[TBL] [Abstract][Full Text] [Related]
12. Secondary sarcomas in childhood cancer survivors: a report from the Childhood Cancer Survivor Study.
Henderson TO; Whitton J; Stovall M; Mertens AC; Mitby P; Friedman D; Strong LC; Hammond S; Neglia JP; Meadows AT; Robison L; Diller L
J Natl Cancer Inst; 2007 Feb; 99(4):300-8. PubMed ID: 17312307
[TBL] [Abstract][Full Text] [Related]
13. Survival rates with uveal melanoma in the United States: 1973-1997.
Singh AD; Topham A
Ophthalmology; 2003 May; 110(5):962-5. PubMed ID: 12750098
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Racial, Ethnic, and Socioeconomic Associations With Treatment and Survival in Uveal Melanoma, 2004-2014.
Rajeshuni N; Zubair T; Ludwig CA; Moshfeghi DM; Mruthyunjaya P
JAMA Ophthalmol; 2020 Aug; 138(8):876-884. PubMed ID: 32614376
[TBL] [Abstract][Full Text] [Related]
15. Mutual Risks of Cutaneous Melanoma and Specific Lymphoid Neoplasms: Second Cancer Occurrence and Survival.
Herr MM; Schonfeld SJ; Dores GM; Withrow DR; Tucker MA; Curtis RE; Morton LM
J Natl Cancer Inst; 2018 Nov; 110(11):1248-1258. PubMed ID: 29659938
[TBL] [Abstract][Full Text] [Related]
16. Second Primary Neoplasms in Patients With Sebaceous Carcinoma of the Eyelid: A Population-based Study, 2000 to 2016.
Tadrosse AF; Tadrosse MF; Ezzat BM; Sadek DM; Langer PD
Ophthalmic Plast Reconstr Surg; 2022 Mar-Apr 01; 38(2):193-198. PubMed ID: 34366382
[TBL] [Abstract][Full Text] [Related]
17. Uveal Melanoma Metastasis to the Contralateral Eye Structures: A Retrospective Comparative Analysis of 13 Consecutive Patients.
Masoomian B; Mashayekhi A; Shields JA; Shields CL
Ophthalmol Retina; 2021 Oct; 5(10):1036-1042. PubMed ID: 33421627
[TBL] [Abstract][Full Text] [Related]
18. The risk of other primary cancer in patients with uveal melanoma: a retrospective cohort study of a Canadian population.
Callejo SA; Al-Khalifa S; Ozdal PC; Edelstein C; Burnier MN
Can J Ophthalmol; 2004 Jun; 39(4):397-402. PubMed ID: 15327105
[TBL] [Abstract][Full Text] [Related]
19. Second Primary Malignancies following a Diagnosis of Conjunctival Melanoma.
Mahjoub H; Loya A; Ayaz T; Weng CY
Curr Eye Res; 2022 Apr; 47(4):634-641. PubMed ID: 34898336
[TBL] [Abstract][Full Text] [Related]
20. Epidemiological trends in uveal melanoma.
Andreoli MT; Mieler WF; Leiderman YI
Br J Ophthalmol; 2015 Nov; 99(11):1550-3. PubMed ID: 25904122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
